Loading clinical trials...
Loading clinical trials...
Primary progressive aphasia (PPA) is a disorder characterized by gradual decline in speech-language ability caused by underlying neurodegenerative disease. PPA is a devastating condition that can affe...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Texas at Austin
Collaborators
NCT06739967 · Primary Progressive Aphasia(PPA)
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
NCT05741853 · Primary Progressive Aphasia, Dementia, and more
NCT03887481 · Logopenic Progressive Aphasia, Primary Progressive Aphasia
NCT07158216 · Primary Progressive Aphasia(PPA)
Memory and Aging Center, University of California, San Francisco
San Francisco, California
University of Texas
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions